Key Clinical Markers That May Influence Your GLP-1 Choice Beyond medication class, several biomarkers and clinical features may provide context for your provider's recommendation
Optimize your long-term health GLP-1 medications activate the gut-hormone receptors that regulate appetite, blood sugar, and how full you feel after eating, supporting weight loss when paired with diet and physical activity
Curiously, CT2 that, in normal conditions, has a very narrow and specific tissue distribution, becomes widely expressed in cancers even originating from tissues in which CT2 is normally not present, further highlighting the carnitine role in human cancers
The latter possibility is consistent with the report that KLF9 acts as a transcriptional mediator of glucocorticoid-regulated, KLF9 family member KLF2 in macrophages to promote inflammation (Chinenov et al., 2014)
Lowering the buildup of toxins can translate to less cellular damage, which in turn can support a healthier biological age
Whether combinations produce additive or synergistic effects across the gene-expression pathways modulated by GHK-Cu remains an open research question [12]
